Investors

News Release Details

Opiant Pharmaceuticals to Participate in September Investor Conferences

August 25, 2021 at 4:05 PM EDT

SANTA MONICA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT) today announced that members of the company’s senior management team will participate in the following virtual investor conferences:

  • H.C. Wainwright 23rd Annual Global Investment Conference
    September 13-15, 2021
    On-demand presentation will be available at 7:00am ET on September 13; hosting 1-on-1 meetings

  • Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
    September 20-23, 2021
    Presentation on September 20 at 4:35 pm ET; hosting 1-on-1 meetings
  • Cantor 2021 Virtual Global Healthcare Conference 
    September 27-30, 2021
    Fireside chat on September 29 at 4:00 pm ET; hosting 1-on-1 meetings

A webcast of each presentation and fireside chat will be accessible on the Opiant website.

About Opiant Pharmaceuticals, Inc. 
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com


Primary Logo

Source: Opiant Pharmaceuticals, Inc.